Showing results (1401-1410 of 1,431) with videos related to
Sort By:
Pageof 144
The Lancet. Neurology|December 15, 2015
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient dataMargaret A Horne, Kelly D Flemming, I-Chang Su, et al.Bioorganic & Medicinal Chemistry|June 29, 2011
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)Wen-Hsing Lin, Shu-Yi Hsieh, Shih-Chieh Yen, et al.Research Square|June 12, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell typesDavid Raleigh, S John Liu, Nazanin Majd, et al.Acta Cardiologica Sinica|May 31, 2018
2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in TaiwanYi-Heng Li, Chih-Yuan Fang, I-Chang Hsieh, et al.Kidney International|February 27, 2021
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseAlfred K Cheung, Tara I Chang, William C Cushman, et al.Annals of Internal Medicine|June 21, 2021
Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice GuidelineCharles R V Tomson, Alfred K Cheung, Johannes F E Mann, et al.European Cardiology|March 12, 2021
2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y<sub>12</sub> Receptor Antagonists in the Asia-Pacific RegionJack Wc Tan, Derek P Chew, Muhamad Ali Sk Abdul Kader, et al.Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.Journal of Clinical Medicine|March 29, 2023
Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in TaiwanPatrick Yan-Tyng Liu, Fang-Ju Lin, Chih-Fan Yeh, et al.Biomedical Journal|August 14, 2023
A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation studyYu-Chung Hsiao, Thung-Lip Lee, Fang-Ju Lin, et al.Pageof 144